India faces a surge in heart attacks, driven by modern lifestyles and silent health risks like high blood pressure and ...

Oral semaglutide improved glycemic parameters and cardiovascular risk factors for adults with overweight or obesity, with ...

Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar ...

Novo Nordisk today presented new data from the OASIS 4 phase 3 trial that explored a variety of patients and hypotheses, ...

Indian researchers identify blood markers for early diabetes and kidney risk, enabling personalized treatment and timely ...

The insights, drawn from data analysed for 14,192 individuals aged 30–40 years, revealed that 59 years were obese and 19 years were overweight ...

Novo Nordisk A/S delivered mixed Q3 '25 results, with modest revenue growth but 27% drop in net profit due to financing costs ...

Both medications have similar side effects, such as stomach issues like diarrhea, nausea, and bloating. However, metformin’s ...

Artificial intelligence (AI) is stepping into the role of a health coach, offering a scalable and personalized approach to diabetes prevention. A recent study from Johns Hopkins University has shown ...

Blessing Resource Center and Hannibal Regional Hospitals host health screening fairs QUINCY–There is no excuse for not ...